98 related articles for article (PubMed ID: 20655904)
1. Protease-activated receptor 1 antagonists prevent platelet aggregation and adhesion without affecting thrombin time.
Nadal-Wollbold F; Bocquet A; Bourbon T; Létienne R; Le Grand B
Eur J Pharmacol; 2010 Oct; 644(1-3):188-94. PubMed ID: 20655904
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the effects of PAR1 antagonists, PAR4 antagonists, and their combinations on thrombin-induced human platelet activation.
Wu CC; Teng CM
Eur J Pharmacol; 2006 Sep; 546(1-3):142-7. PubMed ID: 16890935
[TBL] [Abstract][Full Text] [Related]
3. The novel and orally active thrombin receptor antagonist E5555 (Atopaxar) inhibits arterial thrombosis without affecting bleeding time in guinea pigs.
Kogushi M; Matsuoka T; Kawata T; Kuramochi H; Kawaguchi S; Murakami K; Hiyoshi H; Suzuki S; Kawahara T; Kajiwara A; Hishinuma I
Eur J Pharmacol; 2011 Apr; 657(1-3):131-7. PubMed ID: 21300059
[TBL] [Abstract][Full Text] [Related]
4. The effects of two synthetic glycoprotein IIb/IIIa antagonists, Ro 43-8857 and L-700,462, on platelet aggregation and bleeding in guinea-pigs and dogs: evidence that Ro 43-8857 is orally active.
Cook NS; Bruttger O; Pally C; Hagenbach A
Thromb Haemost; 1993 Nov; 70(5):838-47. PubMed ID: 8128443
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterization of protease activated receptor-1 by a serum responsive element-dependent reporter gene assay: major role of calmodulin.
De Vries L; Palmier C; Finana F; Le Grand B; Perez M; Cussac D
Biochem Pharmacol; 2006 May; 71(10):1449-58. PubMed ID: 16524561
[TBL] [Abstract][Full Text] [Related]
6. Antiplatelet and antithrombotic effect of F 16618, a new thrombin proteinase-activated receptor-1 (PAR1) antagonist.
Dumas M; Nadal-Wollbold F; Gaussem P; Perez M; Mirault T; Létienne R; Bourbon T; Grelac F; Le Grand B; Bachelot-Loza C
Br J Pharmacol; 2012 Mar; 165(6):1827-1835. PubMed ID: 21913899
[TBL] [Abstract][Full Text] [Related]
7. Platelet aggregation and fibrinogen binding in human, rhesus monkey, guinea-pig, hamster and rat blood: activation by ADP and a thrombin receptor peptide and inhibition by glycoprotein IIb/IIIa antagonists.
Cook NS; Zerwes HG; Tapparelli C; Powling M; Singh J; Metternich R; Hagenbach A
Thromb Haemost; 1993 Sep; 70(3):531-9. PubMed ID: 8259560
[TBL] [Abstract][Full Text] [Related]
8. The preparation and characterization of novel peptide antagonists to thrombin and factor VIIa and activation of protease-activated receptor 1.
Nieman MT; Warnock M; Hasan AA; Mahdi F; Lucchesi BR; Brown NJ; Murphey LJ; Schmaier AH
J Pharmacol Exp Ther; 2004 Nov; 311(2):492-501. PubMed ID: 15210836
[TBL] [Abstract][Full Text] [Related]
9. Antithrombotic effects of the novel inhibitor of thrombin-induced offtelet aggregation and thrombus formation, 3-[2-[1,1':2',1"]-terphenyl-4'-yl)ethyl]phenoxyacetic acid.
Miyamae T; Hashizume H; Ogawa T; Okayama T; Nukui E; Oshima K; Morikawa T; Hagiwara M
Arzneimittelforschung; 1997 Jan; 47(1):13-8. PubMed ID: 9037437
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological properties of the novel anti-platelet aggregating agent 4-cyano-5,5-bis(4-methoxyphenyl)-4-pentenoic acid.
Fujimori T; Harada K; Saeki T; Kogushi M; Akasaka K; Yamagishi Y; Yamatsu I
Arzneimittelforschung; 1987 Oct; 37(10):1143-8. PubMed ID: 3124862
[TBL] [Abstract][Full Text] [Related]
11. Anti-thrombotic effects and bleeding risk of AJvW-2, a monoclonal antibody against human von Willebrand factor.
Kageyama S; Yamamoto H; Nagano M; Arisaka H; Kayahara T; Yoshimoto R
Br J Pharmacol; 1997 Sep; 122(1):165-71. PubMed ID: 9298543
[TBL] [Abstract][Full Text] [Related]
12. Discovery of novel protease activated receptors 1 antagonists with potent antithrombotic activity in vivo.
Perez M; Lamothe M; Maraval C; Mirabel E; Loubat C; Planty B; Horn C; Michaux J; Marrot S; Letienne R; Pignier C; Bocquet A; Nadal-Wollbold F; Cussac D; de Vries L; Le Grand B
J Med Chem; 2009 Oct; 52(19):5826-36. PubMed ID: 19791800
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of arterial thrombosis by a protease-activated receptor 1 antagonist, FR171113, in the guinea pig.
Kato Y; Kita Y; Hirasawa-Taniyama Y; Nishio M; Mihara K; Ito K; Yamanaka T; Seki J; Miyata S; Mutoh S
Eur J Pharmacol; 2003 Jul; 473(2-3):163-9. PubMed ID: 12892834
[TBL] [Abstract][Full Text] [Related]
14. Effect of aprotinin and recombinant variants on platelet protease-activated receptor 1 activation.
Day JR; Haskard DO; Taylor KM; Landis RC
Ann Thorac Surg; 2006 Feb; 81(2):619-24. PubMed ID: 16427862
[TBL] [Abstract][Full Text] [Related]
15. Anti-platelet effects of isocarbacyclin methyl ester on human and rabbit platelets in vitro.
Inoue K; Aoki Y; Kitahara S; Kiyoki M; Araki H
Arzneimittelforschung; 1995 Sep; 45(9):975-9. PubMed ID: 7488316
[TBL] [Abstract][Full Text] [Related]
16. Protease-activated receptor-1 mediates thrombin-induced persistent sodium current in human cardiomyocytes.
Pinet C; Algalarrondo V; Sablayrolles S; Le Grand B; Pignier C; Cussac D; Perez M; Hatem SN; Coulombe A
Mol Pharmacol; 2008 Jun; 73(6):1622-31. PubMed ID: 18326052
[TBL] [Abstract][Full Text] [Related]
17. Regulation of protease-activated receptor (PAR) 1 and PAR4 signaling in human platelets by compartmentalized cyclic nucleotide actions.
Bilodeau ML; Hamm HE
J Pharmacol Exp Ther; 2007 Aug; 322(2):778-88. PubMed ID: 17525299
[TBL] [Abstract][Full Text] [Related]
18. The PAR1 antagonist, SCH79797, alters platelet morphology and function independently of PARs.
Lee H; Hamilton JR
Thromb Haemost; 2013 Jan; 109(1):164-7. PubMed ID: 23093354
[No Abstract] [Full Text] [Related]
19. The antithrombotic effect of aurin tricarboxylic acid in the guinea pig is not solely due to its interaction with the von Willebrand factor-GPIb axis.
Azzam K; Cissé-Thiam M; Drouet L
Thromb Haemost; 1996 Jan; 75(1):203-10. PubMed ID: 8713802
[TBL] [Abstract][Full Text] [Related]
20. Species variability in platelet and other cellular responsiveness to thrombin receptor-derived peptides.
Connolly TM; Condra C; Feng DM; Cook JJ; Stranieri MT; Reilly CF; Nutt RF; Gould RJ
Thromb Haemost; 1994 Oct; 72(4):627-33. PubMed ID: 7878643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
